Chemed Corp (CHE.N)

CHE.N

About

Chemed Corporation (Chemed) purchases, operates and divests subsidiaries engaged in diverse business activities. During the year ended December 31, 2012, Chemed operated in two segments: the Vitas segment (Vitas) and the Roto-Rooter segment (Roto-Rooter). Vitas Healthcare Corporation focuses on hospice care, which helps make... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	0.43
Market Cap (Mil.):	$1,374.73
Shares Outstanding (Mil.):	18.87
Dividend:	0.18
Yield (%):	0.99

Financials

	CHE.N	Industry	Sector
P/E (TTM):	15.39	24.63	31.28
EPS (TTM):	4.74	--	--
ROI:	12.88	6.75	18.90
ROE:	19.87	10.88	19.80

Latest News about CHE.N

U.S. sues owner of nation's biggest for-profit hospice chain

WASHINGTON - The U.S. Justice Department is suing Chemed Corp and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.

02 May 2013

U.S. sues owner of nation's biggest for-profit hospice chain

WASHINGTON, May 2 - The U.S. Justice Department is suing Chemed Corp and its hospice subsidiaries, including the biggest U.S. for-profit hospice chain, alleging false billings for Medicare hospice services.

02 May 2013

» More CHE.N News

Competitors

	Price	Change
Gentiva Health Services, Inc. (GTIV.OQ)	$11.66	-0.11
Community Health Systems (CYH.N)	$49.92	+0.07
BioScrip Inc (BIOS.OQ)	$15.98	+0.19
AdCare Health Systems, Inc. (ADK.A)	$4.60	-0.13
Metlifecare Limited (MET.NZ)	$3.28	+0.05

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - CHEMED CORPORATION (CHE-N) Provider: Thomson Reuters Stock Report	$25.00 Buy
Trading Report for (CHE). A detailed report, including free correlated market analysis, and updates. Provider: Stock Traders Daily	$58.00 Buy
The Investment Rate - a measure of investment demand. Provider: Stock Traders Daily	$495.00 Buy
CHEMED CORP (CHE) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Chemed Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.